Woodward, M. Epidemiology. Chapman and Hall/CRC, 2013. DOI:10.1201/b16343CrossRefGoogle Scholar

Livingston, G, Sommerlad, A, Orgeta, V et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734. DOI:10.1016/S0140-6736(17)31363-6Google Scholar

Jorm, AF, Korten, AE, Henderson, AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76(5):465–479. DOI:10.1111/j.1600-0447.1987.tb02906.xCrossRefGoogle ScholarPubMed

Minett, T, Stephan, B, Brayne, C. Epidemiology of old age psychiatry: an overview of concepts and main studies. In Oxford Textbook of Old Age Psychiatry (2nd edn) (eds Dening, T, Thomas, A): 57–85. Oxford University Press, 2013Google Scholar

Castle, DJ, Murray, RM. The Epidemiology of Late-Onset Schizophrenia. Vol 19; 1993. https://academic.oup.com/schizophreniabulletin/article-abstract/19/4/691/1888798. Accessed 13 February 2019.Google Scholar

Jorm, AF. History of depression as a risk factor for dementia: an updated review. Aust New Zeal J Psychiatry. 2001;35(6):776–781. DOI:10.1046/j.1440-1614.2001.00967.xCrossRefGoogle ScholarPubMed

Singh-Manoux, A, Dugravot, A, Fournier, A et al. Trajectories of depressive symptoms before diagnosis of dementia. JAMA Psychiatry. 2017;74(7):712. DOI:10.1001/jamapsychiatry.2017.0660Google Scholar

Sosa-Ortiz, AL, Acosta-Castillo, I, Prince, MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–608. DOI:10.1016/j.arcmed.2012.11.003CrossRefGoogle ScholarPubMed

Yu-Tzu Wu, A, Beiser, AS, B Breteler, MM et al. The changing prevalence and incidence of dementia over time-current evidence. Nat Rev Neurol. 2017;13(6):327. DOI:10.1038/nrneurol.2017.63Google Scholar

Matthews, FE, Arthur, A, Barnes, LE et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet (London, England). 2013;382(9902):1405–1412. DOI:10.1016/S0140-6736(13)61570-6Google Scholar

Wharton, SB, Brayne, C, Savva, GM et al. Epidemiological neuropathology: the MRC cognitive function and aging study experience. J Alzheimer’s Dis. 2011;25(2):359–372. DOI:10.3233/JAD-2011-091402Google Scholar

Snowdon, DA, Nun Study. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med. 2003;139(5 Pt 2):450–454. DOI:10.7326/0003-4819-139-5_part_2-200309021-00014Google Scholar

Bennett, HQ, Norton, S, Bunn, F et al. The impact of dementia on service use by individuals with a comorbid health condition: a comparison of two cross-sectional analyses conducted approximately 10 years apart. BMC Med. 2018;16(1):114. DOI:10.1186/s12916-018-1105-8Google Scholar

He, FJ, Pombo-Rodrigues, S, MacGregor, GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014;4(4):e004549. DOI:10.1136/bmjopen-2013-004549Google Scholar

Marioni, RE, Valenzuela, MJ, van den Hout, A, Brayne, C, Matthews, FE, MRC cognitive function and ageing study. Active cognitive lifestyle is associated with positive cognitive health transitions and compression of morbidity from age sixty-five. Fielding R, ed. PLoS One. 2012;7(12):e50940. DOI:10.1371/journal.pone.0050940Google Scholar

Prince, M, Bryce, R, Albanese, E et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Dement. 2013;9(1):63–75.e2. DOI:10.1016/j.jalz.2012.11.007Google Scholar

Prince, M, Ferri, CP, Acosta, D et al. The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health. 2007;7(1):165. DOI:10.1186/1471-2458-7-165CrossRefGoogle Scholar

Rodriguez, JJL, Ferri, CP, Acosta, D et al. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008;372(9637):464–474. DOI:10.1016/S0140-6736(08)61002-8Google Scholar

Stelzma, RA, Norman Schnitzlein, H, Murllagh, FR. An English Translation of Alzheimer’s 1907 Paper, ‘Ijber Eine Eigenartige Erlranliung Der Hirnrinde’; Vol 8; 1995. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.664.1065&rep=rep1&type=pdf. Accessed 6 February 2019.Google Scholar

Smith, EE. Clinical presentations and epidemiology of vascular dementia. Clin Sci (Lond). 2017;131(11):1059–1068. DOI:10.1042/CS20160607CrossRefGoogle ScholarPubMed

Hughes, JC. Thinking Through Dementia. Oxford University Press, 2011. DOI:10.1093/med/9780199570669.001.0001Google Scholar

Kalaria, RN. The neuropathology of vascular dementia. In Dementia (eds Ames, D, O'Brien, JT, Burns, A): 643–59. 5th ed. CRC Press, 2017.Google Scholar

Lobo, A, Launer, LJ, Fratiglioni, L et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl. 5):S4–S9. www.ncbi.nlm.nih.gov/pubmed/10854354. Accessed 6 February 2019.Google Scholar

Hamilton, RL. Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000;10(3):378–384. www.ncbi.nlm.nih.gov/pubmed/10885656. Accessed 21 October 2019.CrossRefGoogle ScholarPubMed

Barber, R, Panikkar, A, McKeith, IG. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry. 2001; 16 (Suppl. 1):S12–8. www.ncbi.nlm.nih.gov/pubmed/11748785. Accessed 6 February 2019.Google Scholar

Vann Jones, SA, O’Brien, JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014; 44(04):673–683. DOI:10.1017/S0033291713000494Google Scholar

Savica, R, Grossardt, BR, Bower, JH et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013; 70(11): 1396. DOI:10.1001/jamaneurol.2013.3579Google Scholar

Nelson, PT, Schmitt, FA, Jicha, GA et al. Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol. 2010;257(11):1875–1881. DOI:10.1007/s00415-010-5630-4Google Scholar

van der Linde, RM, Dening, T, Stephan, BCM et al. Longitudinal course of behavioural and psychological symptoms of dementia: systematic review. Br J Psychiatry. 2016; 209(5): 366–377. DOI:10.1192/bjp.bp.114.148403CrossRefGoogle ScholarPubMed

Collerton, J, Davies, K, Jagger, C et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2009; 339: b4904. DOI:10.1136/bmj.b4904CrossRefGoogle ScholarPubMed

Kuring, JK, Mathias, JL, Ward, L. Prevalence of depression, anxiety and PTSD in people with dementia: a systematic review and meta-analysis. Neuropsychol Rev. 2018; 28(4): 393–416. DOI:10.1007/s11065-018-9396-2Google Scholar

Kay, DWK, Forster, DP, Newens, AJ. Long-term survival, place of death, and death certification in clinically diagnosed pre-senile dementia in northern England. Br J Psychiatry. 2000;177(2):156–162. DOI:10.1192/bjp.177.2.156Google Scholar

Data Analysis Report: Dying with Dementia. National Dementia Intelligence. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/733065/Dying_with_dementia_data_analysis_report.pdf. Accessed 21 October 2019.Google Scholar

Xie, J, Brayne, C, Matthews, FE, Medical research council cognitive function and ageing study collaborators. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ. 2008;336(7638):258–262. DOI:10.1136/bmj.39433.616678.25Google Scholar

Mitchell, SL, Kiely, DK, Hamel, MB. Dying with advanced dementia in the nursing home. Arch Intern Med. 2004; 164(3): 321. DOI:10.1001/archinte.164.3.321Google Scholar

Sampson, EL, Candy, B, Davis, S et al. Living and dying with advanced dementia: a prospective cohort study of symptoms, service use and care at the end of life. Palliat Med. 2018; 32(3): 668–681. DOI:10.1177/0269216317726443Google Scholar

Ormel, J, VonKorff, M, Ustun, TB et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA. 1994; 272(22): 1741–1748. www.ncbi.nlm.nih.gov/pubmed/7966922. Accessed 8 February 2019.Google Scholar

Beekman, AT, Copeland, JR, Prince, MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307–311. www.ncbi.nlm.nih.gov/pubmed/10533549. Accessed 8 February 2019.Google Scholar

Djernes, JK, Gulmann, NC, Foldager, L, Olesen, F, Munk-Jørgensen, P. 13 year follow up of morbidity, mortality and use of health services among elderly depressed patients and general elderly populations. Aust New Zeal J Psychiatry. 2011;45(8):654–662. DOI:10.3109/00048674.2011.589368Google Scholar

Fiske, A, Wetherell, JL, Gatz, M. Depression in older adults. Annu Rev Clin Psychol. 2009; 5(1): 363–389. DOI:10.1146/annurev.clinpsy.032408.153621Google Scholar

McDougall, FA, Kvaal, K, Matthews, FE et al. Prevalence of depression in older people in England and Wales: the MRC CFA study. Psychol Med. 2007; 37(12): 1787–1795. DOI:10.1017/S0033291707000372Google Scholar

McDougall, FA, Matthews, FE, Kvaal, K, Dewey, ME, Brayne, C. Prevalence and symptomatology of depression in older people living in institutions in England and Wales. Age Ageing. 2007; 36(5): 562–568. DOI:10.1093/ageing/afm111CrossRefGoogle ScholarPubMed

Royal College of Psychiatrists (RCPsych). Improving the Outcome for Older People Admitted to the General Hospital: Guidelines for the Development of Liaison Mental Health Services for Older People. 2005. www.rcpsych.ac.uk/docs/default-source/members/faculties/liaison-psychiatry/cr183liaisonpsych-every-acute-hospital.pdf?sfvrsn=26c57d4_2. Accessed 21 October 2019.Google Scholar

Koenig, HG, Blazer, DG. Epidemiology of geriatric affective disorders. Clin Geriatr Med. 1992;8(2):235–251. DOI:10.1016/S0749-0690(18)30476-2CrossRefGoogle ScholarPubMed

Tariot, PN, Podgorski, CA, Blazina, L, Leibovici, A. Mental disorders in the nursing home: another perspective. Am J Psychiatry. 1993; 150(7): 1063–1069. DOI:10.1176/ajp.150.7.1063Google Scholar

Hirschfeld, RMA, Calabrese, JR, Weissman, MM et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53–59. DOI:10.4088/jcp.v64n0111Google Scholar

Rowland, TA, Marwaha, S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018;8(9):251–269. DOI:10.1177/2045125318769235CrossRefGoogle ScholarPubMed

Oostervink, F, Boomsma, MM, Nolen, WA. Bipolar disorder in the elderly; different effects of age and of age of onset. J Affect Disord. 2009; 116(3): 176–183. DOI:10.1016/j.jad.2008.11.012Google Scholar

Almeida, OP, Fenner, S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatrics. 2002; 14(3): 311–322. www.ncbi.nlm.nih.gov/pubmed/12475092. Accessed 11 February 2019.Google Scholar

Depp, CA JD. Bipolar Disorder in Older Adults: A Critical Review; 2004. https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1399-5618.2004.00139.x. Accessed 11 February 2019.Google Scholar

Pearlson, G, Rabins, P. The late-onset psychoses: possible risk factors. Psychiatr Clin North Am. 1988; 11(1): 15–32. DOI:10.1016/S0193-953X(18)30514-8Google Scholar

Harris, J, Jeste, D. Late onset schizophrenia: an overview. Schizophr Bull. 1988;14(1). https://watermark.silverchair.com/14-1-39.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAmQwggJgBgkqhkiG9w0BBwagggJRMIICTQIBADCCAkYGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMvceOJVaLG0qgF17IAgEQgIICF5zX95t5l1-5fbYYWAFNEcw1miHR3xVYimna1ALr3KE4Q4P. Accessed 13 February 2019.Google Scholar

Stafford, J, Howard, R, Kirkbride, JB. The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960–2016. Psychol Med. 2018; 48(11): 1775–1786. DOI:10.1017/S0033291717003452CrossRefGoogle ScholarPubMed

Overview | Delirium: prevention, diagnosis and management | Guidance | NICE. www.nice.org.uk/guidance/cg103. Accessed 21 October 2019.Google Scholar

Folstein, MF, Bassett, SS, Romanoski, AJ, Nestadt, G. The epidemiology of delirium in the community: the Eastern Baltimore Mental Health Survey. Int Psychogeriatrics. 1991; 3(2): 169–176. www.ncbi.nlm.nih.gov/pubmed/1811771. Accessed 13 February 2019.Google Scholar

Davis, DHJ, Kreisel, SH, Muniz Terrera, G et al. The epidemiology of delirium: challenges and opportunities for population studies. Am J Geriatr Psychiatry. 2013; 21(12): 1173–1189. DOI:10.1016/j.jagp.2013.04.007CrossRefGoogle ScholarPubMed

Davis, DHJ, Muniz Terrera, G, Keage, H et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135(9):2809–2816. DOI:10.1093/brain/aws190CrossRefGoogle Scholar

Blazer, D, George, L HD. The epidemiology of anxiety disorders: an age comparison. – PsycNET. https://psycnet.apa.org/record/1991-97050-002. Published 1991. Accessed 13 February 2019.Google Scholar

Regier, DA, Boyd, JH, Burke, JD et al. One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry. 1988;45(11):977. DOI:10.1001/archpsyc.1988.01800350011002Google Scholar

Andreas, S, Schulz, H, Volkert, J et al. Prevalence of mental disorders in elderly people: the European MentDis_ICF65+ study. Br J Psychiatry. 2017; 210(2): 125–131. DOI:10.1192/bjp.bp.115.180463CrossRefGoogle ScholarPubMed

Mangweth-Matzek, B, Hoek, HW. Epidemiology and treatment of eating disorders in men and women of middle and older age. Curr Opin Psychiatry. 2017;30(6):446–451. DOI:10.1097/YCO.0000000000000356Google Scholar

van Alphen, SPJ, Engelen, GJJA, Kuin, Y, Derksen, JJL. The relevance of a geriatric sub-classification of personality disorders in the DSM-V. Int J Geriatr Psychiatry. 2006; 21(3): 205–209. DOI:10.1002/gps.1451Google Scholar

van Alphen, SPJ (Bas), Derksen, JJL (Jan), Sadavoy, J (Joel), Rosowsky, E (Erlene). Features and challenges of personality disorders in late life. Aging Ment Health. 2012; 16(7): 805–810. DOI:10.1080/13607863.2012.667781Google Scholar

Engels, GI, Duijsens, IJ, Haringsma, R, van Putten, CM. Personality disorders in the elderly compared to four younger age groups: a cross-sectional study of community residents and mental health patients. J Pers Disord. 2003; 17(5): 447–459. www.ncbi.nlm.nih.gov/pubmed/14632377. Accessed 13 February 2019.Google Scholar

Rao, R, Roche, A. Substance misuse in older people. BMJ. 2017; 358: j3885. DOI:10.1136/BMJ.J3885Google Scholar

Khan, N, Davis, P, Wilkinson, T, Sellman, JD GP. Drinking patterns among older people in the community: hidden from medical attention? | Request PDF. New Zeal Med J. 2002; 115(1148): 72–75. www.researchgate.net/publication/11450449_Drinking_patterns_among_older_people_in_the_community_Hidden_from_medical_attention. Accessed 21 October 2019.Google Scholar

Kuerbis, A, Sacco, P, Blazer, DG, Moore, AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–654. DOI:10.1016/j.cger.2014.04.008Google Scholar

Cadieux, RJ. Drug interactions in the elderly. Postgrad Med. 1989;86(8):179–186. DOI:10.1080/00325481.1989.11704506Google Scholar

Hinkin, CH, Castellon, SA, Dickson-Fuhrman, E, Daum, G, Jaffe, J, Jarvik, L. Screening for drug and alcohol abuse among older adults using a modified version of the CAGE. Am J Addict. 2001; 10(4): 319–326. www.ncbi.nlm.nih.gov/pubmed/11783746. Accessed 21 October 2019.Google Scholar

Gunnell, D, Middleton, N, Whitley, E, Dorling, D, Frankel, S. Why are suicide rates rising in young men but falling in the elderly? A time-series analysis of trends in England and Wales 1950–1998. Soc Sci Med. 2003;57(4):595–611. www.ncbi.nlm.nih.gov/pubmed/12821009. Accessed 20 February 2019.Google Scholar

Office for National Statistics. Suicides in the UK: 2017 registrations. ONS. 2017.Google Scholar

Measuring National Well-being – Office for National Statistics. www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/articles/measuringnationalwellbeing/qualityoflifeintheuk2018. Accessed 21 October 2019.Google Scholar

Howard, R, Rabins, PV, Seeman, MV, Jeste, V. Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus and the International Late-Onset Schizophrenia Group. Vol 157; 2000. https://ajp.psychiatryonline.org/doi/pdfplus/10.1176/appi.ajp.157.2.172. Accessed 19 February 2019.Google Scholar

Katzman, R. Education and the prevalence of dementia and Alzheimer’s disease. Neurology. 1993;43: 13–20.Google Scholar

Staff, R, Hogan, M, Williams, D, et al. Intellectual engagement and cognitive ability in later life (the ‘use it or lose it’ conjecture): longitudinal, prospective study. BMJ. 2018;363: k4925.Google Scholar

Burn, K, Szoeke, C. Is grandparenting a form of social engagement that benefits cognition in ageing? Maturitas. 2015;80: 122–5.Google Scholar

Daw, EW, Payami, H, Nemes, EJ, et al. The number of trait loci in late onset Alzheimer disease. American Journal of Human Genetics. 2000;66: 196–204.Google Scholar

Breteler, MM. Vascular risk factors for Alzheimer’s disease: an epidemiological perspective. Neurobiology of Aging. 2000;21: 153–60.Google Scholar

Hachinski, VC, Lassen, NA, Marshall, J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; 304: 207–9.Google Scholar

Erkinjuntti, T, Gauthier, S. Diagnosing vascular cognitive impairment and dementia: concepts and controversies. In Vascular Cognitive Impairment in Clinical Practice (eds Wahlund, LO, Erkinjuntti, T, Gauthier, S): 3–10. Cambridge University Press, 2009.Google Scholar

Boyle, PA, Yu, L, Wilson, RS et al. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 2018; 83: 74–83.Google Scholar

Power, MC, Mormino, E, Soldan, A et al. Combined neuropathological pathways account for age-related risk of dementia Ann Neurol 2018; 84: 10–22.Google Scholar

De Reuck, J, Maurage, C-A, Deremacourt, V et al. Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: a neuropathological study. Folia Neuropathol 2018; 56: 81–87.CrossRefGoogle ScholarPubMed

Niemantsverdriet, E, Feyen, BFE, Le Bastard, N et al. Overdiagnosing vascular dementia using structural brain imaging in dementia work-up. J Alz Dis 2015; 45: 1039–43.Google Scholar

Nagy, ZS, Esiri, MM, Jobst, KA et al. Relative roles of plaques and tangles in the dementia of Alzheimer’s disease: correlations using three sets of neuropathological criteria. Dement Geriat Cogn Dis 1995; 6: 21–31.Google Scholar

Skrobot, OA, Attems, J, Esiri, M et al. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment Brain 2016; 139: 2957–69.Google Scholar

Moorhouse, P, Rockwood, K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurology 2008; 7: 246–55.Google Scholar

Barkhof, F, Fox, NC, Bastos-Leite, AJ, Scheltens, P. Neuroimaging in Dementia. Springer, 2011.Google Scholar

Tatemichi, TK, Desmond, DW, Mayeux, R et al. Dementia after stroke. Neurology 1992; 42: 1185.Google Scholar

Pendlebury, ST, Rothwell, PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurology 2009; 8: 1006–18.Google Scholar

Pendlebury, ST, Rothwell, PM for the Oxford Vascular Study.Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurology 2019; 18:248–58.Google Scholar

Smallwood, A, Oulhaj, A, Joachim, C et al. (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 2012; 38: 337–43.Google Scholar

Dichgans, M and Leys, D. Vascular cognitive impairment. Circ Res 2017; 120: 573–91.CrossRefGoogle ScholarPubMed

van der Flier, W, Staekenborg, SS, Barkhof, F et al. Structural neuroimaging: CT and MRI. In Vascular Cognitive Impairment in Clinical Practice (eds Wahlund, L, Erkinjuntti, T, Gauthier, S): 58–69. Cambridge University Press, 2009.Google Scholar

Erkinjuntti, T, Inzitari, D, Pantoni, L et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm. Supple 2000; 59: 23–30.Google Scholar

Scheltens, P, Erkinjuntti, T, Leys, D et al. White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol 2000; 39: 80–9.Google Scholar

Linn, J, Halpin, A, Demacrel, P et al. Prevalence of superficial siderosis in patients with cerebral congophilic angiopathy. Neurology 2010; 74: 1346–50.CrossRefGoogle Scholar

Charimidou, A, Gang, Q, Werring, DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol, Neurosurg Psychiatry 2012; 83: 124–37.Google Scholar

Ince, G, Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study–MRC CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169–175.Google Scholar

Charlton, RA, Morris, RG, Nitkunan, A, Markus, HS. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006; 66: 1523.Google Scholar

Wiederkehr, S, Simard, M, Fortin, C et al. Validity of the clinical diagnostic criteria for vascular dementia: a critical review. Part II. J Neuropsychiatry Clin Neurosci 2008; 20: 162–77.Google Scholar

Fischer, P, Jellinger, K, Gatterer, G et al. Prospective neuropathological validation of Hachinski’s Ischaemic Score in dementias. J Neurol, Neurosurg Psychiatry 1991; 54: 580.Google Scholar

Rockwood, K, Davis, H, MacKnight, C et al. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. Can J Neurol Sci 2003; 30: 237–43.CrossRefGoogle Scholar

Verhey, FRJ, Lodder, J, Rozendaal, N et al. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996; 15: 166–72.CrossRefGoogle ScholarPubMed

O’Brien, JT, Erkinjuntti, T, Reisberg, B et al. Vascular cognitive impairment. Lancet Neurology 2003; 2: 89–98.CrossRefGoogle ScholarPubMed

Sachdev, PS, Looi, JCL. Neuropsychological differentiation of Alzheimer’s Disease and vascular dementia. In Vascular Cognitive Impairment: Preventable Dementia (eds Bowler, JV, Hachinski, V): 152–176. Oxford University Press, 2003.Google Scholar

Price, CC, Jefferson, AL, Merino, JG et al. Subcortical vascular dementia. Neurology 2005; 65: 376–82.Google Scholar

Hachinski, V, Iadecola, C, Petersen, RC et al. National institute of neurological disorders and stroke-Canadian stroke network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220–41.Google Scholar

Hebert, R, Brayne, C. Epidemiology of vascular dementia. Neuroepidemiology 1995; 14: 240–57.Google Scholar

Ueda, K, Kawano, H, Hasuo, Y et al. Prevalence and etiology of dementia in a Japanese community. Stroke 1992; 23: 798.Google Scholar

Ikeda, M, Hokoishi, K, Maki, N et al. Increased prevalence of vascular dementia in Japan. Neurology 2001; 57: 839.Google Scholar

Fratiglioni, L, Launer, LJ, Andersen, K et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54: S10–5.Google Scholar

Hebert, R, Lindsay, J, Verreault, R et al. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000; 31: 1487.Google Scholar

Lopez, OL, Wolk, DA. Clinical evaluation: a systematic but user-friendly approach. In Vascular Cognitive Impairment in Clinical Practice (eds Wahlund, L, Erkinjuntti, T, Gauthier, S): 32–45. Cambridge University Press, 2009.Google Scholar

Wilcock, GK, Bucks, RS, Rockwood, K. Diagnosis and Management of Dementia: A Manual for Memory Disorders Teams. Oxford University Press, 1999.CrossRefGoogle Scholar

Hodges, JR. Cognitive Assessment for Clinicians. 3rd edn. Oxford University Press, 2018.Google Scholar

Smith, AD, Smith, SM, de Jager, CA et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PloS One 2010; 5: e12244.Google Scholar

Wald, DS, Kasturiratne, A, Simmonds, M. Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alz Dement 2011; 7: 412–17.Google ScholarPubMed

NICE. Dementia: supporting people with dementia and their carers in health and social care. Clinical Guideline 42 (amended March 2011). National Institute for Health and Clinical Excellence.Google Scholar

Alexopoulos, GS, Abrams, RC, Young, RC et al. Cornell scale for depression in dementia. Biol Psychiat 1988; 23: 271–84.CrossRefGoogle ScholarPubMed

Black, S, Román, GC, Geldmacher, DS et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34: 2323–32.Google Scholar

Wilkinson, D, Doody, R, Helme, R et al. Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003; 61: 479–86.Google Scholar

Wilkinson, DG, Doody, RS, Black, SE et al. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord 2005; 20: 338–44.Google Scholar

Erkinjuntti, T, Kurz, A, Gauthier, S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283–90.Google Scholar

Mok, V, Wong, A, Ho, S et al. Rivastigmine in Chinese patients with subcortical vascular dementia. Neuropsychiatr Dis Treat 2007; 3(6): 943–8.Google Scholar

Ballard, C, Sauter, M, Scheltens, P et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin 2008; 24(9):2561–74.Google Scholar

Orgogozo, J, Rigaud, A, Stoffler, A et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002; 33: 1834–9.Google Scholar

Wilcock, G, Möbius, HJ, Stöffler, A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002; 17: 297–305.Google Scholar

NICE. Alzheimer’s disease – donepezil, galantamine, rivastigmine and memantine. Technology Appraisal 217. National Institute for Health and Clinical Excellence, 2011.Google Scholar

Erkinjuntti, T, Román, G, Gauthier, S et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004; 35: 1010.Google Scholar

Román, G. Therapeutic strategies for vascular dementia. In Dementia (eds Burns, A, O’Brien, J, Ames, D): 574–600. Hodder Arnold, 2005.Google Scholar

Bahar-Fuchs, A, Clare, L, Woods, B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD003260.Google Scholar

Alexopoulos, GS, Meyers, BS, Young, RC et al. ‘Vascular depression’ hypothesis. Arch Gen Psychiat 1997; 54: 915–22.Google Scholar

Sheline, YI, Pieper, CF, Barch, DM et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiat 2010; 67: 277–85.Google Scholar

Banerjee, S. The Use of Antipsychotic Medication for People with Dementia: Time for Action. Department of Health, London, 2009.Google Scholar

McGuinness, B, Todd, S, Passmore, P et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database. John Wiley & Sons, 2009.Google Scholar

Forette, F, Seux, ML, Staessen, JA et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Int Med 2002; 162: 2046–52.CrossRefGoogle ScholarPubMed

Tzourio, C, Anderson, C, PROGRESS Collaborative Group et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Int Med 2003; 163: 1069–75.Google Scholar

Bowler, JV. Modern concept of vascular cognitive impairment. Br Med Bull 2007; 83: 291–305.Google Scholar

World Health Organization. International Classification of Diseases 11th Revision. WHO, 2019. Last accessed on 18 October 2019 via: https://icd.who.int/ct11/icd11_mms/en/releaseGoogle Scholar

Kaiser, S, Panegyres, PK. The psychosocial impact of young onset dementia on spouses. Am J Alzheimers Dis Other Demen 2006; 21: 398–402.Google Scholar

Harvey, R. Young Onset Dementia: Epidemiology, Clinical Symptoms, Family Burden, Support and Outcome. Dementia Research Group, 1998.Google Scholar

Knapp, M, Prince, M. Dementia UK: The Full Report. Alzheimer’s Society, 2007. Last accessed on 18 October 2019 via: www.alzheimers.org.uk/sites/default/files/2018-10/Dementia_UK_Full_Report_2007.pdf?fileID=2Google Scholar

Prince, M, Knapp, M, Guerchet, M et al. Dementia UK: Update. Second edition. Alzheimer’s Society, 2014. Last accessed on 18 October 2019 via: www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_uk_update.pdfGoogle Scholar

Folstein, MF, Folstein, SE, McHugh, PR.‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12: 189–198.Google Scholar

Mathuranath, PS, Nestor, PJ, Berrios, GE, Rakowicz, W, Hodges, JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 2000; 55: 1613–1620.Google Scholar

Hodges, JR, Larner, AJ. Cognitive Screening Instruments: A Practical Approach. Second Edition. Springer; 2017.Google Scholar

Schott, JM, Fox, NC, Rossor, MN. Genetics of the dementias. J Neurol Neurosurg Psychiatry 2002; 73(suppl II): ii27–31.Google Scholar

Ratnavalli, E, Brayne, C, Dawson, K, Hodges, JR. (2002) The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615–1621.Google Scholar

Nestor, P. Frontotemporal dementia. In Dementia (Fifth Edition) (eds. Ames, D, O’Brien, J, Burns, A): 749–758. CRC Press, Taylor & Francis Group, 2017.Google Scholar

Rascovsky, K, Hodges, JR, Knopman, D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456–2477. DOI:10.1093/brain/awr179Google Scholar

McKeith, IG, Boeve, BF, Dickson, DW et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017; 89: 88–100. DOI:10.1212/WNL.0000000000004058Google Scholar

Chua, P, Loi, S, Chiu, E. Huntingon’s disease. In Dementia (Fifth Edition) (eds. Ames, D, O’Brien, J, Burns, A): 868–884. CRC Press, Taylor & Francis Group, 2017.Google Scholar

Kurz, A, Lautenschlager, NT. Established treatments for Alzheimer’s disease. In Dementia (Fifth Edition) (eds. Ames, D, O’Brien, J, Burns, A): 539–553. CRC Press, Taylor & Francis Group, 2017.Google Scholar

National Institute for Health and Care Excellence (NICE). Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers. NICE Guideline 97. NICE, 2018. Last accessed on 3 October 2019 via: www.nice.org.uk/guidance/ng97/resources/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109Google Scholar

Scales, K, Zimmerman, S, Miller, SJ. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia. Gerontologist 2018; 58(Suppl. 1):S88–S102.Google Scholar

www.youngdementiauk.org/about-us [Last accessed on 18 October 2019.]Google Scholar

Williams, T, Dearden, AM, Cameron, IH. From pillar to post: a study of younger people with dementia. Psychiatr Bull 2001; 25: 384–387.Google Scholar

Fuhrmann, R. Early-Onset Dementia in Brighton, Hove and Lewes Area: Prevalence and Service Needs. Alzheimer’s Society (Brighton branch), 1997.Google Scholar

National Institute for Health and Clinical Excellence, Social Care Institute for Excellence (NICE-SCIE). Dementia: Supporting People with Dementia and their Carers in Health and Social Care. British Psychological Society and Gaskill, 2007.Google Scholar

National Institute for Health and Care Excellence (NICE). Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers. NICE Guideline 97. NICE, 2018. Last accessed on 3 October 2019 via: www.nice.org.uk/guidance/ng97/resources/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109Google Scholar

Royal College of Psychiatrists. Young-Onset Dementia in Mental Health Services CR217. Royal College of Psychiatrists, 2018. Last accessed on 18 October 2019 via: www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/college-reports/2018-college-reports/cr217Google Scholar

Alzheimer Europe. Rare Forms of Dementia. Last accessed on 27 September 2019 via: www.alzheimer-europe.org/Dementia/Other-forms-of-dementia.Google Scholar

Sampson, EL, Warren, JD, Rossor, MN. Young onset dementia. Postgrad Med J 2004; 80: 125–139.Google Scholar

Jellinger, K, Ala, TA, Beh, GO et al. Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer’s disease. Neurology 2000; 55: 735–742.Google Scholar

Honig, LS, Scarmeas, N, Hatanpaa, KJ et al. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 2005; 64: 1102.Google Scholar

Mahapatra, RK, Edwards, MJ, Schott, JM, Bhatia, KP. Corticobasal degeneration. Lancet Neurol 2004; 3: 736–743.Google Scholar

Yekhlef, F, Ballan, G, Macia, F et al. Routine MRI for the differential diagnosis of Parkinson’s disease, MSA, PSP, and CBD. J Neural Transm 2003; 110: 151–169.Google Scholar

Rehman, HU. Multiple system atrophy. Postgrad Med J 2001; 77: 379–382.Google Scholar

McDermott, CJ, Shaw, PJ. Diagnosis and management of motor neurone disease. BMJ 2008; 336: 658–662.Google Scholar

Dharmadasa, T, Kiernan, M. Riluzole, disease stage and survival in ALS. Lancet Neurol 2018; 17: 385–386. http://dx.doi.org/10.1016/S1474-4422(18)30091-7Google Scholar

van de Warrenburg, BPC, Verschuuren–Bemelmans, CC, Scheffer, H et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002; 58: 702–708.Google Scholar

Schöls, P, Bauer, T, Schmidt, T et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291–304.Google Scholar

Kondo, T, Takahashi, K, Kohara, M et al. Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease): Three genetic forms. Neurology 2002; 59: 1105–1107.Google Scholar

Di Donato, I, Silvia Bianchi, S, De Stefano, N. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med 2017; 15: 41. DOI:10.1186/s12916-017-0778-8.Google Scholar

Prusiner, SB. Human prion diseases. Ann Neurol 1994; 35: 385–395.Google Scholar

World Health Organization. WHO Manual for Surveillance of Human Transmissible Spongiform Encephalopathies. WHO, 2003.Google Scholar

European Centre for Disease Prevention and Control. Facts about variant Creutzfeldt-Jakob disease, 2017. Last accessed on27 September 2019 via: https://ecdc.europa.eu/en/vcjd/factsGoogle Scholar

European Centre for Disease Prevention and Control. Surveillance Report – Annual Epidemiological Report for 2016: Creutzfeldt−Jakob Disease. Last accessed on27 September 2019 via: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2016-Creutzfeldt-Jakob-disease.pdfGoogle Scholar

Zeidler, M, Johnstone, EC, Bamber, RW et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350: 908–910.Google Scholar

Almeida, OP, Flicker, L, Lautenschlager, NT. Uncommon causes of dementia: rare, but not marginal. Int Psychogeriatr 2005; 17: 1–2.Google Scholar

National Institute for Health and Care Excellence. NICE Guideline – Lyme disease. NICE, 2018. Last accessed on 27 September 2019 via: www.nice.org.uk/guidance/ng95Google Scholar

Almeida, OP, Lautenschlager, NT. Dementia associated with infectious diseases. Int Psychogeriatr 2005; 17: 65–77.Google Scholar

Richartz, E, Buchkremer, G. Cerebral toxocariasis: a rare cause of cognitive disorders. A contribution to differential dementia diagnosis. Nervenarzt 2002; 73: 458–462.Google Scholar

Solomon, T, Hart, I, Beeching, N. Viral encephalitis: a clinician’s guide, Brit Med J 2007; 7: 288–305.Google Scholar

Grant, I, Sacktor, N, McArthur, J. HIV neurocognitive disorders. In The Neurology of AIDS (2nd edn) (eds. Gendelman, HE, Grant, I, Everall, IP, Lipton, SA, Swindells, S): 357–373. Oxford University Press, 2005.Google Scholar

Garg, RK. Subacute sclerosing panencephalitis. Postgrad Med J 2002; 78: 63–70.Google Scholar

Wills, AJ, Pengiran Tengah, DSNA, Holmes, GKT. The neurology of enteric disease. J Neurol Neurosurg Psychiatry 2006; 77: 805–810.Google Scholar

Chisolm, JJ Jr. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures. Environ Health Perspect 1990; 89: 67–74.Google Scholar

Dobson, AW, Erikson, KM, Aschner, M. Manganese neurotoxicity. Ann N Y Acad Sci 2004; 1012: 115–129.Google Scholar

Zatta, P, Lucchini, R, van Rensburg, SJ et al. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 2003; 62: 15–28.Google Scholar

Campbell, A. The potential role of aluminium in Alzheimer’s disease. Nephrol Dial Transplant 2002; 17(suppl 2): 17–20.Google Scholar

Kamel, F, Hoppin, JA. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 2004; 112: 950–958.Google Scholar

Hayden, KM, Norton, MC, Darcey, D et al. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology 2010; 74: 1524–1530.Google Scholar

Pachet, AK, Wisniewski, AM. The effects of lithium on cognition: an updated review. Psychopharmacol 2003; 170: 225–234.Google Scholar

Nunes, PV, Forlenza, OV, Gattaz, WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry 2007; 190: 359–360.Google Scholar

Moncrieff, J, Leo, J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med 2010; 40: 1409–1422.Google Scholar

Gray, SL, Anderson, ML, Dublin, S et al. Cumulative use of strong anticholinergic medications and incident dementia. JAMA Intern Med 2015; 175: 401–407.Google Scholar

Richardson, K, Fox, C, Maidment, I et al. Anticholinergic drugs and risk of dementia: case-control study. Brit Med J 2018; 360: k1315.Google Scholar

Coupland, CAC, Hill, T, Dening, T et al. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med 2019; 179: 1084–1093.Google Scholar

Wang, Y-C, Tai, P-A, Poly, TN. Increased risk of dementia in patients with antidepressants: a meta-analysis of observational studies. Behav Neurol 2018, 5315098. https://doi.org/10.1155/2018/5315098 (last accessed 30 October 2019).Google Scholar

Ruffner-Statzer, S, Bernstein, AL. A persistent dementia-like condition following treatment of Hepatitis C with pegylated interferon and ribavirin. Gastroenterol Hepatol 2008; 4: 63–65.Google Scholar

Valentine, AD, Meyers, CA, Talpaz, M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Investig 1995; 13: 561–566.Google Scholar

Varney, NR, Alexander, B, MacIndoe, JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 1984; 141: 369–372.Google Scholar

Wolkowitz, OM, Lupien, SJ, Bigler, E et al. The ‘steroid dementia syndrome’: An unrecognized complication of glucocorticoid treatment. Ann N Y Acad Sci 2004; 1032: 191–194.Google Scholar

Clarke, R, Smith, D, Jobst, KA et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449–1455.Google Scholar

Fleminger, S, Oliver, DL, Lovestone, S et al. Head injury as a risk factor for Alzheimer’s disease. The evidence 10 years on: a partial replication. J Neurol Neurosurg Psychiatry 2003; 74: 857–862.Google Scholar

Mackay, DF, Russell, ER, Stewart, K, et al. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med 2019; 381:1801–1808.Google Scholar

Ernst, A, Zibrak, JD. Carbon monoxide poisoning. N Engl J Med 1998; 339: 1603–1608.Google Scholar

Choi, IS. Parkinsonism after carbon monoxide poisoning. Eur J Neurol 2002; 48: 30–33.Google Scholar

Zola-Morgan, S, Squire, LR, Amaral, DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986; 6: 2950–2967.Google Scholar

Mehta, KM, Ott, A, Kalmijn, S et al. Head trauma and risk of dementia and Alzheimer’s disease: the Rotterdam study. Neurology 1999; 53: 1959–1962.Google Scholar

Fogelholm, R, Waltimo, O. Epidemiology of chronic subdural haematoma. Acta Neurochir 1975; 32: 247–250.Google Scholar

Sahyouni, R, Goshtasbi, K, Mahmoodi, A, Tran, DK, Chen, JW. Chronic subdural hematoma: a perspective on subdural membranes and dementia. World Neurosurg 2017; 108: 954–958.Google Scholar

Vanderpump, MP, Turnbridge, WM, French, JM. The incidence of thyroid disorder in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43: 55–68.Google Scholar

de Jong, FJ, Masaki, K, Chen, H et al. Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia Aging Study. Neurobiol Aging 2009; 30: 600–606.Google Scholar

Watson, LC, Marx, CE. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomatics 2002; 43: 413–417.Google Scholar

Cheng, G, Huang, C, Deng, H, Wang, H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42: 484–491.Google Scholar

Awad, N, Gagnon, M, Messier, C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044–1080.Google Scholar

McAdams-DeMarco, MA, Daubresse, M, Bae, S et al. Dementia, Alzheimer’s disease, and mortality after hemodialysis Initiation. Clin J Am Soc Nephrol 2018; 13: 1339–1347.Google Scholar

Sternlieb, I. Perspectives on Wilson’s disease. Hepatology 1990; 12: 1234–1239.Google Scholar

Estrov, Y, Scaglia, F, Bodamer, OA. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis 2000; 23: 2–6.Google Scholar

Jarman, PR, Wood, NW. Genetics of movement disorders and ataxia. J Neurol Neurosurg Psychiatry 2002; 73(Suppl. 2): 22–26.Google Scholar

Scaravilli, F, An, SF, Groves, M et al. The neuropathology of paraneoplastic syndromes. Brain Pathol 1999; 9: 251–260.Google Scholar

Keime-Guibert, F, Graus, F, Fleury, A et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000; 68: 479–482.Google Scholar

Rickards, H, Jacob, S, Lennox, B et al. Autoimmune encephalitis: a potentially treatable cause of mental disorder. Adv Psychiatr Treat 2014; 20: 92–100.Google Scholar

Kalb, R, Feinstein, A, Rohrig, A, Sankary, L, Willis, A. Depression and suicidality in multiple sclerosis: red flags, management strategies, and ethical considerations. Curr Neurol Neurosci Rep 2019; 19: 77.Google Scholar

Jefferies, K. The neuropsychiatry of multiple sclerosis. Adv Psychiatr Treat 2006; 12: 214–220.Google Scholar

Krupp, LB, Christodoulou, C, Melville, P et al. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579–1585.CrossRefGoogle ScholarPubMed

Wirnsberger, RM, De Vries, J, Wouters, EF et al. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study. Netherlands J Med 1998; 53: 53–60.Google Scholar

Kuker, W. Cerebral vasculitis: imaging signs revisited. Neuroradiology 2007; 49: 471–479.Google Scholar

Collin, P, Pirttila, T, Nurmikko, T et al. Celiac disease, brain atrophy and dementia. Neurology 1991; 41: 372–375.Google Scholar

William, TH, Joseph, AM, Melanie, CG et al. Cognitive impairment and celiac disease. Arch Neurol 2006; 63: 1440–1446.Google Scholar

Kaklamani, VG, Variopoulos, G, Kaklamanis, PG. Behçet’s disease. Semin Arthritis Rheum 1998; 27: 197–217.Google Scholar

Lishman, WA. Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. Blackwell Publishing, 1998.Google Scholar

Akman-Demir, G, Baykan-Kurt, B, Serdaroglu, P et al. Seven-year follow-up of neurologic involvement in Behçet syndrome. Arch Neurol 1996; 53: 691–694.Google Scholar

Kirk, A, Kertesz, A, Polk, MJ. Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 1991; 18: 344–348.Google Scholar

Ampélas, JF, Wattiaux, MJ, van Amerongen, AP. Psychiatric manifestations of lupus erythematosus systemic and Sjogren’s syndrome [article in French]. L’Encéphale 2001; 27: 588–599.Google Scholar

Brooks, JO, Hoblyn, JC. Secondary mania in older adults. Am J Psychiatry 2005; 162: 2033–8.Google Scholar

Depp, CA, Jeste, DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 6: 343–67.Google Scholar

World Health Organization. ICD-11 for Mortality and Morbidity Statistics (ICD-11 MMS). WHO, 2018. https://icd.who.int/browse11/l-m/en (last accessed 23 October 2019).Google Scholar

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5). American Psychiatric Publishing, 2013.Google Scholar

Goodwin, GM, Haddad, PM, Ferrier, IN et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology, J Psychopharmacol 2016; 30: 495–553.Google Scholar

Krauthammer, C, Klerman, GL. Secondary mania. Manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 1978; 35: 1333–9.Google Scholar

Schneck, CD. Bipolar disorder in neurologic illness. Curr Treat Options Neurol 2002; 4: 477–86.Google Scholar

Shulman, KI, Herrmann, N. Manic syndromes in old age. In Oxford Textbook of Old Age Psychiatry (eds. Jacoby, R, Oppenheimer, C, Dening, T, Thomas, A): 557–62. Oxford University Press, 2008.Google Scholar

Tohen, M, Shulman, KI, Satlin, A. First episode mania in late life. Am J Psychiatry 1994; 151: 130–2.Google Scholar

Sami, M, Khan, H, Nilforooshan, R. Late onset mania as an organic syndrome: a review of case reports in the literature. J Affect Disord 2015; 188: 226–31.Google Scholar

Steffans, DC, Krishnan, KRR. Structural neuroimaging and mood disorders. Recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705–12.Google Scholar

Alexopoulous, GS, Meyers, BS, Young, RC et al. Clinically defined vascular depression. Am J Psychiatry 1997; 154: 562–65.Google Scholar

Tamashiro, JH, Zung, S, Zanetti, MV et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord 2008; 10: 765–75.Google Scholar

McCrone, P, Dhanasiri, S, Patel, A et al. Paying the Price. The Cost of Mental Health Care in England to 2026. King’s Fund, 2008.Google Scholar

Byers, AL, Yaffe, K, Covinsky, KE et al. High occurrence of mood and anxiety disorders among older adults. Arch Gen Psychiatry 2010; 67: 489–96.Google Scholar

Almeida, OP, Fenner, S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr 2002; 14: 311–22.Google Scholar

Dols, A, Kupka, RW, van Lammeren, et al. The prevalence of late-life mania: a review. Bipolar Disord 2014; 16:113–18.Google Scholar

Hirschfeld, RM, Calabrese, JR, Weissman, MM et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53–9.Google Scholar

Bartels, S, Forester, B, Miles, K et al. Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am J Geriatr Psychiatry 2000; 8: 160–6.Google Scholar

Sajatovic, M, Blow, FC, Ignacio, RV. Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry 2006; 21: 582–7.Google Scholar

Naylor, C, Das, P, Ross, S et al. Bringing Together Physical and Mental Health: A New Frontier for Integrated Care. The King’s Fund, 2016. Last accessed 17 October 2019 via: www.kingsfund.org.uk/publications/physical-and-mental-healthGoogle Scholar

Beyer, J, Kuchibhatla, M, Gersing, K et al. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005; 30: 401–4.Google Scholar

Sajatovic, M, Strejilevich, SA, Gildengers, AG et al. A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord 2015; 17: 689–704.Google Scholar

Fiedorowicz, JD, Solomon, DA, Endicott, J et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009; 71: 598–606.Google Scholar

Morriss, R. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol 2005: 19: 94–101.Google Scholar

Aizenberg, D, Olmer, A, Barak, Y. Suicide attempts amongst elderly bipolar patients. J Affect Disord 2006; 91: 91–4.Google Scholar

Keks, NA, Hill, C, Sundram, S et al. Evaluation of treatment in 35 cases of bipolar suicide. Aust N Z J Psychiatry 2009; 43: 503–8.Google Scholar

Kennedy, GJ. Bipolar disorder in late life: mania. Prim Psychiatry 2008; 15: 28–33.Google Scholar

Abovesh, A, Stone, C, Hobbs, WR. Antimicrobial induced mania (antibiomania). A review of spontaneous reports. J Clin Psychopharmacol 2002; 22: 71–81.Google Scholar

Scottish Intercollegiate Guidelines Network. Bipolar Affective Disorder. A National Clinical Guideline. SIGN, 2005. Last accessed on 17 October 2019 via: www.sign.ac.uk/pdf/sign82.pdfGoogle Scholar

Goldstein, BI, Herrmann, N, Shulman, KI. Comorbidity in bipolar disorder among the elderly. Results from an epidemiological community sample. Am J Psychiatry 2006; 163: 319–21.Google Scholar

Schouws, SNTM, Comijs, HC, Stek, ML et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 508–15.Google Scholar

Schouws, SN, Zoeteman, JB, Comijs, HC et al. Cognitive functioning in elderly patients with early onset bipolar disorder. Int J Geriatr Psychiatry 2007; 22: 856–61.Google Scholar

National Institute for Health and Clinical Excellence. Bipolar Disorder. Assessment and Management. Clinical guideline [CG185] NICE, 2014 (updated 2018). Last accessed 17 October 2019 via: www.nice.org.uk/guidance/cg185Google Scholar

De Fazio, P, Gaetano, R, Caroleo, M et al. Lithium in late-life mania: a systematic review. Neuropsychiatr Dis Treat 2017; 13: 755–66.Google Scholar

Young, RC, Mulsant, BH, Sajatovic, M et al. GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. Am J Psychiatry 2017; 174: 1086–93.Google Scholar

Shulman, KI, Rochon, P, Sykora, K et al. Changing prescription patterns for lithium and valproic acid in old age. Shifting practice without evidence. Brit Med J 2003; 326: 960–1.Google Scholar

Fotso Soh, J, Klil-Drori, S, Rei, S. Using lithium in older age bipolar disorder: special considerations. Drugs Aging 2019; 36: 147–54.Google Scholar

Nunes, PV, Forlenza, OV, Gattaz, WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry 2007; 190: 359–60.Google Scholar

Diniz, BS, Machado-Vieira, R, Forlenza, OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat 2013; 9: 493–500.Google Scholar

Hetmar, O, Povlsen, UJ, Ladefoged, J et al. Lithium: long-term effects on the kidney. A prospective follow-up study ten years after kidney biopsy. Br J Psychiatry 1991; 158: 53–8.Google Scholar

Rej, S, Beaulieu, S, Segal, M et al. Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life. Drugs Aging 2014; 31: 911–6.Google Scholar

Kripalani, M, Shawcross, J, Reilly, J et al. Lithium and chronic kidney disease. BMJ 2009; 339: 166–70.Google Scholar

Sajatovic, M. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry 2002; 17: 865–73.Google Scholar

Walstra, G. Reversible dementia due to valproic acid therapy. Ned Tijdschr Geneeskd 1997; 141: 391–93.Google Scholar

Schreur, L, Middeljans-Tijssen, C, Hengstman, G et al. Cognitive impairment and parkinsonism due to the use of sodium valproate. Tijdschr Gerontol Geriatr 2009; 40: 29–33.Google Scholar

Livingston, G, Sommerlad, A, Orgeta, V et al. The Lancet Commissions. Dementia prevention, intervention, and care. Lancet 2017; 390: 2673–734.Google Scholar

National Institute for Health and Care Excellence. Guidance on the Use of Electroconvulsive Therapy, TA59. NICE, 2003. Last accessed 17 October 2019 via: www.nice.org.uk/guidance/ta59Google Scholar

Department of Health. (2009) New Horizons: A Shared Vision for Mental Health. Department of Health, 2009. Last accessed on 17 October 2019 via: www.ndti.org.uk/uploads/files/New_Horizons_A_Shared_Vision_For_Mental_Health_PDF.pdfGoogle Scholar

Chiang, K-J, Tsai, J-C, Liu, D et al. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: a meta-analysis of randomized controlled trials. PLoS ONE 2017; 12(5): e0176849. https://doi.org/10.1371/journal.pone.0176849 (last accessed 23 October 2019).Google Scholar

Mueser, KT, Pratt, SI, Bartels, SJ et al. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. J Consult Clin Psychol 2010; 78: 561–73.Google Scholar

Bartels, SJ, Pratt, SI, Mueser, KT et al. Long-term outcomes of a randomized trial of integrated skills training and preventive health care for older adults with serious mental illness. Am J Geriatr Psychiatry 2014; 22: 1251–61.Google Scholar

Oostervink, F, Nolen, WA, Kok, RM. Two years’ outcome of acute mania in bipolar disorder: different effects of age and age of onset, Int J Geriatr Psychiatry 2015; 30: 201–9.Google Scholar

Shulman, KI, Herrmann, N. The nature and management of mania in old age. Psychiatr Clin North Am 1999; 22: 649–65.Google Scholar

Patient.info. Bipolar Disorder. Patient Information Publications. Patient.info, 2017. Last accessed on 17 October 2019 via: https://patient.info/health/bipolar-disorder-leafletGoogle Scholar

Royal College of Psychiatrists. Bipolar Disorder. RCPsych, 2019. Last accessed on 17 October 2019 via: www.rcpsych.ac.uk/mental-health/problems-disorders/bipolar-disorderGoogle Scholar

Crome, I, Dar, K, Janikiewicz, S et al. Our Invisible Addicts (College Report CR165). Royal College of Psychiatrists, 2011.Google Scholar

Royal College of Psyhciatrists. Our Invisible Addicts, 2nd edition (College Report CR211). Royal College of Psychiatrists, 2018. Last accessed 1 October 2019 via: www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/college-report-cr211.pdf?sfvrsn=820fe4bc_2Google Scholar

Rao, RT, Crome, I, Crome, P et al. Substance Misuse in Older People: An Information Guide (Cross-Faculty Report OA/AP/01). Royal College of Psychiatrists, 2015.Google Scholar

Office for National Statistics. Drinking Habits among Adults 2012. ONS, 2013. Last accessed 25 September 2019 via: www.ons.gov.uk/ons/dcp171778_338863.pdfGoogle Scholar

Office for National Statistics. Adult Drinking Habits in Great Britain: 2005 to 2016. ONS, 2017. Last accessed 25 September 2019 via: www.ons.gov.uk/releases/adultdrinkinghabitsingreatbritain2015Google Scholar

Rao, R. Substance misuse in older people. BMJ 2017; 358: j3885.Google Scholar

Alcohol Concern. Alcohol and the Mental Health of Older People. Alcohol Concern, 2013.Google Scholar

Office for National Statistics. 2011 Census, Population and Household Estimates for the United Kingdom. ONS, 2012. Last accessed 25 September 2019 via: www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-270247Google Scholar

Schonfeld, L, Dupree, LW. Antecedents of drinking for early- and late-onset elderly alcohol abusers. J Stud Alcohol 1991; 52: 587–92.Google Scholar

Van den Berg, JF, Kok, RM, van Marwijk, HW et al. Correlates of alcohol abstinence and at-risk alcohol consumption in older adults with depression: the NESDO study. Am J Geriatr Psychiatry 2014; 22: 866–74.Google Scholar

Ewing, JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252: 1905–7.Google Scholar

Roberts, AME, Marshall, J, Macdonald, AJD. Which screening test for alcohol consumption is best associated with ‘at risk’ drinking in older primary care attenders? Prim Care Ment Health 2005; 3: 131–8.Google Scholar

Philpot, M, Pearson, N, Petratou, V et al. Screening for problem drinking in older people referred to a mental health service: a comparison of CAGE and AUDIT. Aging Ment Health 2003; 7: 171–5.Google Scholar

Aalto, M, Alho, H, Halme, J et al. The Alcohol Use Disorders Identification Test (AUDIT) and its derivatives in screening for heavy drinking among the elderly. Int J Geriatr Psychiatry 2011; 26: 881–5.Google Scholar

Blow, FC, Gillespie, BW, Barry, KL. Brief screening for alcohol problems in elderly populations using the Short Michigan Alcoholism Screening Test–Geriatric Version (SMAST-G). Alcohol Clin Exp Res 1998; 22 (Suppl. 3): 131A.Google Scholar

Alcohol Concern. 15:15 The Case for Better Access to Treatment for Alcohol Dependence in England. Alcohol Concern, 2013.Google Scholar

Schonfeld, L, King-Kallimanis, BL, Duchene, DM et al. Screening and brief intervention for substance misuse among older adults: the Florida BRITE project. Am J Public Health 2010; 100: 108–14.Google Scholar

Borok, J, Galier, P, Dinolfo, M et al. Why do older unhealthy drinkers decide to make changes or not in their alcohol consumption? Data from the Healthy Living as You Age Study. J Am Geriatr Soc 2013; 61: 1296–302.Google Scholar

Oslin, D, Grantham, S, Coakley, E et al. PRISM-E: comparison of integrated care and enhanced specialty referral in managing at-risk alcohol use. Psychiatr Serv 2006; 57: 954–8.Google Scholar

Copello, A, Orford, J. Addiction and the family: is it time for services to take notice of the evidence? Addiction 2002; 97: 1361–3.Google Scholar

AdFam. Parental Substance Misuse: Through the Eyes of the Worker. AdFam, 2013.Google Scholar

Wadd, S, Lapwort, K, Sullivan, M et al. Working with Older Drinkers. University of Bedfordshire, 2011.Google Scholar

Rockett, IR, Putnam, SL, Jia, H et al. Declared and undeclared substance use among emergency department patients: a population-based study. Addiction 2006; 101: 706–12.Google Scholar

Finlayson, R, Hurt, R, Davis, L et al. Alcoholism in elderly persons: a study of the psychiatric and psychosocial features of 216 inpatients. Mayo Clin Proc 1988; 63: 761–8.Google Scholar

Moos, RH, Schutte, K, Brennan, P et al. Ten-year patterns of alcohol consumption and drinking problems among older women and men. Addiction 2004; 99: 829–38.Google Scholar

Orford, J, Copello, A, Velleman, R et al. Family members affected by a close relative’s addiction: the stress-strain-coping-support model. Drugs (Abingdon Engl) 2010; 17 (Suppl. 1): 36–43.Google Scholar

Oslin, D, Atkinson, R, Smith, D et al. Alcohol related dementia: proposed clinical criteria. Int J Geriatr Psychiatry 1998; 13: 203–12.Google Scholar

Sechi, G, Serra, A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007; 6: 442–55.Google Scholar

So, YT, Simon, RP. Deficiency diseases of the nervous system. In Bradley’s Neurology in Clinical Practice (6th ed.) (eds. Daroff, RB, Fenichel, GM, Jankovic, J, Mazziotta, JC): 1340–52. Saunders, 2012.Google Scholar

Mayo-Smith, MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997; 278: 144–51.Google Scholar

Office for National Statistics. Suicides in the UK: 2017 Registrations. ONS, 2017. Last accessed 26 September 2019 via: www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/suicidesintheunitedkingdom/2017registrationsGoogle Scholar

Conwell, Y, van Orden, K, Caine, ED. Suicide in older adults. Psychiatr Clin North Am 2011; 34: 451–68.Google Scholar

Ramstedt, M. Alcohol and suicide in 14 European countries. Addiction 2001; 96: 59–75.Google Scholar

Hawton, K, Casañas, I, Comabella, C et al. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disorders 2013; 147: 17–28.Google Scholar

Kirchner, JE, Zubritsky, C, Cody, M et al. Alcohol consumption among older adults in primary care. J Gen Intern Med 2007; 22: 92–7.Google Scholar

Conner, KR, Beautrais, AL, Conwell, Y. Moderators of the relationship between alcohol dependence and suicide and medically serious suicide attempts: analyses of Canterbury Suicide Project data. Alcohol Clin Exp Res 2003; 27: 1156–61.Google Scholar

Conner, KR, Conwell, Y. Age-related patterns of factors associated with completed suicide in men with alcohol dependence. Am J Addict 1999; 8: 312–8.Google Scholar

Pharmaceutical Press. Stockley’s Drug Interactions. Pharmaceutical Press, 2012.Google Scholar

Gallagher, P, O’Mahony, D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008; 37: 673–9.Google Scholar

Lishman, WA. Alcohol and the brain. Br J Psychiatry 1990; 156: 635–44.Google Scholar

Harvey, RJ, Rossor, MN, Skelton-Robinson, M et al. Young Onset Dementia: Epidemiology, Clinical Symptoms, Family Burden, Support and Outcome. Dementia Research Group, Imperial College, 1998.Google Scholar

Harper, CG, Sheedy, D, Halliday, GM et al. Neuropathological studies: the relationship between alcohol and aging. In Alcohol Problems and Aging (eds. Gomberg, ESL, Hegedus, AM, Zucker, RA) NIAAA Research Monograph no. 33: 117–34. National Institute on Alcohol Abuse and Alcoholism, 1998.Google Scholar

Zahr, NM, Kaufman, KL, Harper, CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 2011; 7: 284–94.Google Scholar

Mioshi, E, Dawson, K, Mitchell, J et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078–85.Google Scholar

MacRae, R, Cox, S. Meeting the Needs of People with Alcohol Related Brain Damage: A Literature Review on the Existing and Recommended Service Provision and Models of Care. Dementia Services Development Centre, University of Stirling, 2003.Google Scholar

Rao, R. Outcomes from liaison psychiatry referrals for older people with alcohol use disorders in the UK. Ment Health Subst Use 2013; 6: 362–8.Google Scholar

Rao, R, Shanks, A. Development and implementation of a dual diagnosis strategy for older people in south east London. Adv Dual Diagn 2011; 4: 28–35.Google Scholar

Rao, R, Draper, B. Alcohol related brain damage in older people. Lancet Psychiatry 2015; 2: 674–45.Google Scholar

Academy of Medical Royal Colleges. Alcohol and Other Drugs: Core Medical Competencies (Occasional Paper OP85). Royal College of Psychiatrists, 2012.Google Scholar

Saxton, L, Lancashire, S, Kipping, C. Meeting the training needs of staff working with older people with dual diagnosis. Adv Dual Diagn 2011; 4: 36–46.Google Scholar

Crome, I, Wu, LT, Rao, RT, Crome, P. (eds.) Substance Use and Older People. John Wiley & Sons, 2014.Google Scholar

Atkinson, MR. Substance abuse in elderly, In Psychiatry in the Elderly (eds Jacoby, R, Oppenheimer, C) 799–834 Oxford University Press, 2002.Google Scholar

Coulthard, M, Farrell, M, Singleton, N et al. Tobacco, Alcohol and Drug Use and Mental Health. TSO (The Stationery Office) 2002.Google Scholar

McInnes, E, Powell, J. Drug and alcohol referrals. Are elderly substance abuse diagnosis and referrals missed? BMJ 1994; 308; 444–446.Google Scholar

Fahmy, V, Hatch, SL, Hotopf M and Stewart R. Prevalence of illicit drug use in people aged 50 years and over from two surveys. Age Ageing (2012); 41, 553–556.Google Scholar

White, JB, Duncan, DF, Bradley, D et al. Generational shift and drug abuse in older Americans. J Soc Behav Health Sci (2011); 5; 58–66.Google Scholar

Moore, AA, Karno, MP, Grella, CE et al. Alcohol, tobacco, and non-medical drug use in older US adults: data from the 2001/02 National Epidemiological Survey of Alcohol and Related Conditions. J Am Geriatr Soc (2009); 57; 2275–2281.Google Scholar

Lin, JC, Karno, MP, Grella, CE et al. Alcohol, tobacco, and non-medical drug use in US adults aged 65 and older: Data from the 2001/02 National Epidemiological Survey of Alcohol and Related Conditions. Am J Geriatr Psychiatry (2011); 19; 291–299.Google Scholar

Blazer, DG and Wu, LT. The epidemiology of substance use and disorders among middle aged and elderly community adults: National Survey on Drug Use and Health (NSDUH). Am J Geriatr Psychiatry (2009); 17;237–245.Google Scholar

Johnson, SD, Striley C and Cottlet LB. Comorbid substance use and HIV risk in older African American drug users. J Aging Health (2007); 19; 646–658.Google Scholar

Lofwall, MR, Schuster A and Strain SK. Changing profile of abused substances by older persons entering treatment. J Nerv Ment Dis (2008); 196; 898–905.Google Scholar

Morgan, K, Dallosso, H, Ebrahim, S et al. Prevalence, frequency, and duration of hypnotic drug use among elderly living at home. BMJ (Clinical Research Edn 1988); 296; 601–602.Google Scholar

Centre for Behavioral Health Statistics and Quality Results from the 2011 National Survey on Drug Use and Health: Mental Health Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville MD (2012).Google Scholar

Cimolai, N. Zopiclone: is it a pharmacological agent for abuse? Canadian Family Physician (2007); 53; 2124–2129.Google Scholar

Higgitt, AC. Indications for benzodiazepine prescriptions in the elderly. Int J Geriatr Psychiatry (1988); 3; 239–243.Google Scholar

Lechevallier, N, Fourier, A, Berr, C. Benzodiazepines in the elderly. The EVA study [In French] Revuew d’Epidemiologieet de Sante Publique (2003); 51; 317–326.Google Scholar

Fernandez, L, Cassagne-Pinel, C. Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects. L’Encephale (2001); 27; 459–474.Google Scholar

Woo, BKP, Chen, W. Substance misuse among older patients in psychiatric emergency service. Gen Hosp Psychiatry (2010); 32; 99–101.Google Scholar

Rajaratnam, R, Sivesind, D, Todman, M et al. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J Opioid Mang (2009); 5; 27–37.Google Scholar

Beynon, CM, McVeigh, J and Roe, B. Problematic drug use, ageing and older people: trends in the age of drug users in northwest England, Ageing Soc (2007); 27; 799–810.Google Scholar

Rivers, E, Shirazi, E, Aurora, T et al. Cocaine use in elderly patients presenting to an inner-city emergency department. Acad Emergency Med(2004); 11; 874–877.Google Scholar

Trafton, JA, Olivia, E, Horst, D et al. Treatment needs associated with pain in substance use disorder patients. Implications of concurrent treatment. Drug and Alcohol Dependence (2004); 73; 23–31.Google Scholar

Simoni-Wastila, L, Stricker, G. Risk Factors associated with problem use of prescription drugs. Am J Pub Health (2004); 94; 266–268.Google Scholar

Gottlieb, S. Inappropriate drug prescribing in elderly people is common. BMJ (2004); 329; 367.Google Scholar

Mossley, JM Shapiro, E. Physician use by elderly over an eight year period. J Pub Health (1985); 75; 133–134.Google Scholar

Gfroerer, J, Penne, M, Pemberton, M et al. Substance abuse treatment among older adults in 2020. The impact of aging baby-boom cohort. Drug and Alcohol Dependence (2003); 69; 127–135.Google Scholar

Hinkin, CH, Castellon, SA, Dickson-Fuhrman, E et al. Screening for drug and alcohol abuse among older adults using modified version of CAGE. Am J Addict (2001); 10; 319–326.Google Scholar

SAMHSA Treatment Episodes Data Set-Admissions (TEDS-A)-Concatenated, 1992–2010. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). ICPSR25221-v5. Inter-university Consortium for Political and Social Research, Ann Arbor, MI (2012).Google Scholar

Frischer, M, Crome, I, Macleod, J et al. Substance misuse and psychiatric illness: prospective observational study using the general practice database. J Epi Comm (2005); 59; 847–850.Google Scholar

Blixen, CE, McDougall, GJ, Suen, LJ. Dual diagnosis in elders discharged from a psychiatric hospital. Int J Geriatr Psychiatry (1997); 12; 307–313.Google Scholar

Rosen, D, Smith, ML, Reynolds, CF. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry (2008); 16; 488–497.Google Scholar

Torres, LR, Kaplan, C, Valdez, A. Health consequences of long-term injection heroin use among aging Mexican American men. J Aging Health (2011); 23; 912–932.Google Scholar

McMorn, S, Schoedel, KA, Sellers, EM. Effects of low-dose opioids on cognitive dysfunction. JCO (2011); 29; 4342–4343.Google Scholar

Sartre, DD, Blow, FC, Chi, Fw, Weisner, C. Gender differences in seven-year alcohol and drug treatment outcomes among older adults. Am J Addict (2007); 16; 216–221.Google Scholar

Outlaw, FH, Marquart, JM, Roy, A et al. Treatment outcomes for older adults who abuse substances. J Appl Gereontol (2012); 31; 78–100.Google Scholar

Miller, PM, Brooks, SW & Stewart, SH. Medical treatment of alcohol dependence: a systematic review. Int J of Psychiatry Med (2011); 42; 227–66.Google Scholar

Picton, JD, Marino, AD & Nealy, KL. Benzodiazepine use and cognitive decline in the elderly. Am J of Health-Sys Pharm (2018); 75; e6–e12Google Scholar

Klingelhoefer, L, Reichmann, H. Pathogenesis of Parkinson disease: the gut-brain axis and environmental factors. Nat Rev Neurol 2015; 11: 625–36.Google Scholar

Chaudhuri, KR, Prieto-Jurcynska, C, Naidu, Y et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010 30; 25: 704–9.Google Scholar

Politis, M, Wu, K, Molloy, S et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 2010; 25: 1646–51.Google Scholar

Weintraub, D, Burn, DJ. Parkinson’s disease: the quintessential neuropsychiatric disorder. Mov Disord 2011; 26: 1022–31.Google Scholar

Perepezko, K, Hinkle, JT, Shepard, MD et al. Social role functioning in Parkinson’s disease: a mixed-methods systematic review. Int Journal Geriatr Psychiatry 2019; 34: 1128–38.Google Scholar

Parkinson, J. An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones; 1817.Google Scholar

Reijnders, JSAM, Ehrt, U, Weber, WEJ, Aarsland, D, Leentjens, AFG. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 2008; 23: 183–9.Google Scholar

Huse, D, Schulman, K, Orsini, L et al. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 2005; 20: 1449–54.Google Scholar

Findley, L, Eichhorn, T, Janca, A et al. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 2002; 17: 60–7.Google Scholar

Dissanayaka, NNW, Sellbach, A, Silburn, PA et al. Factors associated with depression in Parkinson’s disease. J Affect Disord 2011; 132: 82–8.Google Scholar

Pagonabarraga, J, Kulisevsky, J, Strafella, AP, Krack, P. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 2015; 14: 518–31.Google Scholar

Shulman, L, Taback, R, Rabinstein, A, Weiner, W. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Park Relat Disord 2002; 8: 193–7.Google Scholar

Marsh, L, McDonald, WM, Cummings, J et al. Provisional diagnostic criteria for depression in Parkinson’s disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148–58.Google Scholar

Riedel, O, Klotsche, J, Spottke, A et al. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease. J Neurol 2010; 257: 1073–82.Google Scholar

van der Velden, RMJ, Broen, MPG, Kuijf, ML, Leentjens, AFG. Frequency of mood and anxiety fluctuations in Parkinson’s disease patients with motor fluctuations: a systematic review. Mov Disord 2018; 33: 1521–7.Google Scholar

Barone, P, Poewe, W, Albrecht, S et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9: 573–80.Google Scholar

Richard, IH, Kurlan, R, Tanner, C et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson’s disease. Parkinson Study Group. Neurology 1997; 48: 1070–7.Google Scholar

Ghazi-Noori, S, Chung, TH, Deane, K, Rickards, HE, Clarke, CE. Therapies for depression in Parkinson’s disease. Cochrane Database Syst Rev 2003; Issue 2. Art. No.: CD003465. [Republished in 2010 with no changes to the conclusions.]Google Scholar

Starkstein, SE, Brockman, S. Management of depression in Parkinson’s Disease: a systematic review. Mov Disord Clin Pract 2017; 4: 470–7.Google Scholar

den Brok, MGHE, van Dalen, JW, van Gool, WA, Moll van Charante EP, de Bie RMA, Richard E. Apathy in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 2015; 30: 759–69.Google Scholar

Marin, RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243–54.Google Scholar

Pagonabarraga, J, Kulisevsky, J, Strafella, AP, Krack, P. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 2015; 14: 518–31.Google Scholar